Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
43.10
0.26 (0.61%)
At close: May 01, 2025, 2:50 PM
Cytokinetics Revenue
Cytokinetics reported an annual revenue of $18.47M, reflecting a 145.34% growth. For the quarter ending December 31, 2024, Cytokinetics generated $16.93M in revenue.
Revenue (ttm)
$18.47M
Revenue Growth
145.34%
Price / Sales Ratio
285.13
Revenue / Employee
$37.1K
Employees
498
Market Cap
5.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 18.47M | +145.34% |
| Dec 31, 2023 | 7.53M | -92.04% |
| Dec 31, 2022 | 94.59M | +34.30% |
| Dec 31, 2021 | 70.43M | +26.15% |
| Dec 31, 2020 | 55.83M | n/a |